• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.82% Nasdaq Up 0.70%

    More On ATHJF

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Antisense Therapeutics Ltd. (ATHJF)

    -Other OTC
    0.02 0.00(0.00%) May 19
    Prev Close:0.02
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:5.6899
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:0.02 - 0.10
    Volume:0
    Avg Vol (3m):618
    Market Cap:3.53M
    P/E (ttm):10.00
    EPS (ttm):0.00
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    • No Headlines available for ATHJF at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1.09
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Antisense Therapeutics Ltd. engages in the research, development, and commercialization of novel antisense pharmaceuticals in Australia. The company’s product pipeline comprises ATL1102, an antisense inhibitor targeting VLA-4 for the treatmen... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback